Latest news
Loading news…
Vironexis Biotherapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 High growthGrowth score — momentum trend across web traffic, headcount and other growth signals. California, Kentucky, United States Founded 2021 11-50 employees For Profit
Vironexis has the potential to transform immunotherapy and the way cancer is treated in the future.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Patents
2
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 9
- Patents granted
- 2
- Trademarks
- 0
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $262K
Company Info
- Founded
- 2021
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- News articles
- 1
- HQ
- California, Kentucky, United States
- Region
- Southern US
Signals & Scores
- Heat score
- Low
- Growth score
- High
- Trend (7d)
- 0.1
- Trend (30d)
- 2.5
- Trend (90d)
- 1.3
Key People at Vironexis Biotherapeutics
CEO & Board Member
Co-Founder & Board Member
Co-Founder
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Vironexis Biotherapeutics
Loading news…
FAQs about Vironexis Biotherapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.